| Completed | 3 | 12537 | US, Canada, Europe, RoW | insulin glargine (HOE901), Lantus®, omega-3 polyunsaturated fatty acids (PUFA), Omacor®, placebo, reusable pen device for insulin injection, OptiPen® Pro 1 | Sanofi, Population Health Research Institute | Diabetes Mellitus, Non-Insulin-Dependent | 12/11 | 12/11 | | |
